Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
Authors:
Open Access
- 3 March 2011
- journal article
- review article
- Published by Hindawi Limited in Journal of Pregnancy
- Vol. 2011, 1-10
Abstract
The placenta plays a central role in governing local circulatory system that mediates maternal condition and fetal growth. In early gestational phases, the placenta exerts properties of invasion and neovascularization for successful placentation. Extravillous invasive trophoblasts replace uterine endometrial vasculature and establish local blood pathway to obtain oxygen and nutrients from the mother. In later phases, the placenta promotes villous angiogenesis and vascular maturation that are finely controlled by angiogenic and antiangiogenic molecules. Among various molecules involved in placental neovascularization, vascular endothelial growth factor receptors (VEGFRs) and angiotensin II receptor type 1 (AT1) mediate important signaling pathways for maternal circulatory system and fetal growth. VEGFR1 and VEGFR2 are functional receptors for placental growth factor (PlGF) and VEGF, respectively, and PlGF-VEGFR1 and VEGF-VEGFR2 interactions are disturbed in many preeclamptic patients by excess amount of soluble form of VEGFR1 (also named sFlt1), a natural PlGF/VEGF antagonist. Recent studies have disclosed that excessive sFlt1 production in the placenta and aberrant AT1 signaling in the mother are closely associated with the pathology of preeclampsia and intrauterine growth restriction (IUGR). In this paper, neovascularization of the placenta and pathological events associated with disrupted balance between angiogenic and antiangiogenic signaling in preeclampsia are discussed.Keywords
This publication has 96 references indexed in Scilit:
- Cellular and Molecular Regulation of Spiral Artery Remodelling: Lessons from the Cardiovascular FieldPlacenta, 2010
- The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsiaJournal of Experimental Medicine, 2009
- Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant miceNature Medicine, 2008
- A Novel Human-Specific Soluble Vascular Endothelial Growth Factor Receptor 1Circulation Research, 2008
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- Angiotensin II Induces Soluble fms-Like Tyrosine Kinase-1 Release via Calcineurin Signaling Pathway in PregnancyCirculation Research, 2007
- Corneal avascularity is due to soluble VEGF receptor-1Nature, 2006
- An antiangiogenic neurokinin-B/thromboxane A2 regulatory axisJournal of Cell Biology, 2006
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993